- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.88 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x H72: 4-[5-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide(Non-covalent)
- 30 x FMT: FORMIC ACID(Non-functional Binders)
FMT.2: 9 residues within 4Å:- Chain A: G.1, P.2, L.3, S.4
- Chain B: Q.211, L.224, F.225, H.227, F.262
Ligand excluded by PLIPFMT.3: 7 residues within 4Å:- Chain A: R.22, C.95, Q.97, D.98, G.99, P.100, L.102
Ligand excluded by PLIPFMT.4: 5 residues within 4Å:- Chain A: Y.107, A.108, K.109, A.184, E.185
Ligand excluded by PLIPFMT.5: 2 residues within 4Å:- Chain A: K.41, T.55
Ligand excluded by PLIPFMT.6: 4 residues within 4Å:- Chain A: H.87, W.157, Q.158, K.188
Ligand excluded by PLIPFMT.7: 5 residues within 4Å:- Chain A: R.118, T.247, L.248, G.249, G.250
Ligand excluded by PLIPFMT.8: 7 residues within 4Å:- Chain A: Q.211, G.212, M.219, S.223, H.227, Y.229
- Chain B: P.67
Ligand excluded by PLIPFMT.9: 5 residues within 4Å:- Chain A: K.29, L.31, K.41, Y.107, K.109
Ligand excluded by PLIPFMT.10: 4 residues within 4Å:- Chain A: L.47, K.48, R.50, T.54
Ligand excluded by PLIPFMT.11: 5 residues within 4Å:- Chain A: S.6, R.71, L.74, S.75, N.78
Ligand excluded by PLIPFMT.12: 4 residues within 4Å:- Chain A: H.85, Q.161, Q.164, Y.165
Ligand excluded by PLIPFMT.13: 2 residues within 4Å:- Chain A: F.225, D.226
Ligand excluded by PLIPFMT.14: 9 residues within 4Å:- Chain A: R.174, D.175, L.176, A.177, R.179, I.214, P.215, W.218, S.237
Ligand excluded by PLIPFMT.15: 7 residues within 4Å:- Chain A: R.174, L.196, R.198, K.208, G.212, R.213, I.214
Ligand excluded by PLIPFMT.16: 4 residues within 4Å:- Chain A: R.270, W.289, K.290, Q.291
Ligand excluded by PLIPFMT.18: 9 residues within 4Å:- Chain A: Q.211, L.224, F.225, H.227, F.262
- Chain B: G.1, P.2, L.3, S.4
Ligand excluded by PLIPFMT.19: 7 residues within 4Å:- Chain B: R.22, C.95, Q.97, D.98, G.99, P.100, L.102
Ligand excluded by PLIPFMT.20: 5 residues within 4Å:- Chain B: Y.107, A.108, K.109, A.184, E.185
Ligand excluded by PLIPFMT.21: 2 residues within 4Å:- Chain B: K.41, T.55
Ligand excluded by PLIPFMT.22: 4 residues within 4Å:- Chain B: H.87, W.157, Q.158, K.188
Ligand excluded by PLIPFMT.23: 5 residues within 4Å:- Chain B: R.118, T.247, L.248, G.249, G.250
Ligand excluded by PLIPFMT.24: 7 residues within 4Å:- Chain A: P.67
- Chain B: Q.211, G.212, M.219, S.223, H.227, Y.229
Ligand excluded by PLIPFMT.25: 5 residues within 4Å:- Chain B: K.29, L.31, K.41, Y.107, K.109
Ligand excluded by PLIPFMT.26: 4 residues within 4Å:- Chain B: L.47, K.48, R.50, T.54
Ligand excluded by PLIPFMT.27: 5 residues within 4Å:- Chain B: S.6, R.71, L.74, S.75, N.78
Ligand excluded by PLIPFMT.28: 4 residues within 4Å:- Chain B: H.85, Q.161, Q.164, Y.165
Ligand excluded by PLIPFMT.29: 2 residues within 4Å:- Chain B: F.225, D.226
Ligand excluded by PLIPFMT.30: 9 residues within 4Å:- Chain B: R.174, D.175, L.176, A.177, R.179, I.214, P.215, W.218, S.237
Ligand excluded by PLIPFMT.31: 7 residues within 4Å:- Chain B: R.174, L.196, R.198, K.208, G.212, R.213, I.214
Ligand excluded by PLIPFMT.32: 4 residues within 4Å:- Chain B: R.270, W.289, K.290, Q.291
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Newton, R. et al., Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RETV804MKinase. Acs Med.Chem.Lett. (2020)
- Release Date
- 2020-03-11
- Peptides
- Proto-oncogene tyrosine-protein kinase receptor Ret: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.88 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x H72: 4-[5-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide(Non-covalent)
- 30 x FMT: FORMIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Newton, R. et al., Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RETV804MKinase. Acs Med.Chem.Lett. (2020)
- Release Date
- 2020-03-11
- Peptides
- Proto-oncogene tyrosine-protein kinase receptor Ret: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A